Skip to main content
OpenTrials

Clinical trial condition

Glycogen Storage Disease Type II

Explore clinical trials studying Glycogen Storage Disease Type II. Study availability and eligibility vary by location and protocol.

22 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Glycogen Storage Disease Type II trial results

Completed

Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease

NCT00074932

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Colorado Health Science Center Aurora, Colorado, United States
  • Galichia Heart Hospital Wichita, Kansas, United States
  • Genzyme Medical Information Cambridge, Massachusetts, United States
  • Freeman Health Systems Joplin, Missouri, United States
View Trial Details
Completed

Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602

NCT00125879

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Miami Children's Hospital Miami, Florida, United States
  • Emory University Medical Genetics Decatur, Georgia, United States
View all 14 locations
View Trial Details
Completed

rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)

NCT00053573

Conditions
Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +15 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Pediatrique Hopital de Brousse Lyon, France
View Trial Details
Completed

Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies

NCT00763932

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Children's Hospital of Oakland Oakland, California, United States
  • Children's Hospital of Orange Country Orange, California, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Institute for Genetic Medicine, Saint Peter's University Hospital New Brunswick, New Jersey, United States
View Trial Details
Completed

A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease

NCT00059280

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • University of Utah Medical Center Salt Lake City, Utah, United States
View Trial Details
Completed

A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease

NCT00515398

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Washington University St Louis, Missouri, United States
  • Center for Metabolic Disorders Lake Success, New York, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)

NCT04848779

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • Advanced Medical Genetics- Site Number : 8400002 Hawthorne, New York, United States
  • Duke University Medical Center- Site Number : 8400004 Durham, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center- Site Number : 8400001 Cincinnati, Ohio, United States
  • Le Bonheur Children's Hospital- Site Number : 8400005 Memphis, Tennessee, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa

NCT04910776

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • Stanford Hospital- Site Number : 8400006 Stanford, California, United States
  • Children's Hospitals and Clinics of Minnesota- Site Number : 8400008 Minneapolis, Minnesota, United States
  • Advanced Medical Genetics- Site Number : 8400002 Hawthorne, New York, United States
  • Duke University Medical Center- Site Number : 8400004 Durham, North Carolina, United States
View all 16 locations
View Trial Details

Related conditions